WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Stock Ownership - Who owns Arrowhead Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Arrowhead Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
James C. HamiltonChief DiscoveryTrans Medicine2024-04-016,000$28.03
$168.18kSell
Hongbo LuDirector2024-03-201,000$27.50
$27.50kBuy
Hongbo LuDirector2024-03-191,000$28.00
$28.00kBuy
Hongbo LuDirector2024-03-181,000$27.49
$27.49kBuy
Kenneth Allen MyszkowskiChief Financial Officer2024-03-0640,000$35.19
$1.41MSell
Christopher Richard AnzaloneChief Executive Officer2024-01-3157,499$14.54
$836.04kBuy
Christopher Richard AnzaloneChief Executive Officer2024-01-3137,769$32.16
$1.21MSell
Christopher Richard AnzaloneChief Executive Officer2024-01-3119,730$32.71
$645.37kSell
James C. HamiltonChief DiscoveryTrans Medicine2024-01-124,238$36.47
$154.56kSell
James C. HamiltonChief DiscoveryTrans Medicine2024-01-123,702$37.37
$138.34kSell

1 of 7

ARWR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARWR insiders and whales buy or sell their stock.

ARWR Shareholders

What type of owners hold Arrowhead Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.74%13,303,757$316.36MInstitution
Vanguard Group Inc8.61%10,672,076$253.78MInstitution
State Street Corp5.51%6,825,111$162.30MInstitution
David M. Knott4.53%5,609,690$133.40MInsider
Christopher Richard Anzalone3.00%3,715,048$88.34MInsider
Fmr LLC2.72%3,371,268$80.17MInstitution
Jpmorgan Chase Co2.22%2,751,048$65.42MInstitution
Geode Capital Management LLC1.88%2,326,876$55.33MInstitution
Invesco Ltd1.86%2,306,308$54.84MInstitution
Credit Suisse Ag 11.41%1,745,342$41.50MInstitution

1 of 3

ARWR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARWR62.55%10.70%Net SellingNet Selling
IMCR75.26%0.07%Net BuyingNet Buying
IDYA88.70%10.03%Net SellingNet Selling
XENE95.45%3.29%Net SellingNet Selling
ACLX44.19%55.81%Net SellingNet Selling
View Top Biotech Stocks

Arrowhead Pharmaceuticals Stock Ownership FAQ

Who owns Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals (NASDAQ: ARWR) is owned by 62.55% institutional shareholders, 10.70% Arrowhead Pharmaceuticals insiders, and 26.75% retail investors. David M. Knott is the largest individual Arrowhead Pharmaceuticals shareholder, owning 5.61M shares representing 4.53% of the company. David M. Knott's Arrowhead Pharmaceuticals shares are currently valued at $130.65M.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.